Compare NC & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NC | NBY |
|---|---|---|
| Founded | 1913 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 401.3M | 398.2M |
| IPO Year | 2006 | 2007 |
| Metric | NC | NBY |
|---|---|---|
| Price | $56.74 | $1.54 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.7K | ★ 1.5M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.71% | N/A |
| EPS Growth | ★ 186.01 | 35.42 |
| EPS | ★ 2.87 | 0.76 |
| Revenue | ★ $104,778,000.00 | $370,000.00 |
| Revenue This Year | N/A | $23.91 |
| Revenue Next Year | N/A | $32.05 |
| P/E Ratio | $20.55 | ★ $2.04 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $30.00 | $0.43 |
| 52 Week High | $58.99 | $19.95 |
| Indicator | NC | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 60.71 | 44.12 |
| Support Level | $44.66 | $0.94 |
| Resistance Level | $58.74 | $2.52 |
| Average True Range (ATR) | 1.76 | 0.23 |
| MACD | 0.07 | 0.30 |
| Stochastic Oscillator | 66.52 | 46.74 |
NACCO Industries Inc is a holding company that operates in the mining and natural resource industries. It has three operating segments that are coal mining, North American mining (NA mining), and minerals management. The majority of its revenue is from the coal mining segment. This segment operates surface coal mines under long-term contracts with power generation companies and an activated carbon producer pursuant to a service-based business model. The NA mining segment provides value-add contract mining and services for producers. Minerals management generates income from royalty-based leases by acquiring and promoting oil, gas, and coal mineral interests. The company is diversifying beyond coal mining due to political and economic pressures associated with carbon emissions.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.